Cargando…

Vitamin C Urinary Loss in Fabry Disease: Clinical and Genomic Factors of Vitamin C Renal Leak

OBJECTIVES: Reduced plasma vitamin C concentrations in chronic diseases may result from abnormal urinary excretion of vitamin C excretion: a renal leak. We hypothesized that vitamin C renal leak may be the consequence of disease-mediated dysregulation affecting the renal tubules, resulting in aberra...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebenuwa, Ifechukwude, Violet, Pierre-Christian, Padayatty, Sebastian, Tu, Hongbin, Wang, Yaohui, Eck, Peter, Wilkins, Kenneth, Moore, David, Schiffmann, Raphael, Levine, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194231/
http://dx.doi.org/10.1093/cdn/nzac074.009
Descripción
Sumario:OBJECTIVES: Reduced plasma vitamin C concentrations in chronic diseases may result from abnormal urinary excretion of vitamin C excretion: a renal leak. We hypothesized that vitamin C renal leak may be the consequence of disease-mediated dysregulation affecting the renal tubules, resulting in aberrant vitamin C renal reabsorption and increased urinary loss. The study objective was to investigate the prevalence, clinical characteristics, and genomic associations of vitamin C renal leak in Fabry disease, an X-linked lysosomal storage disease associated with renal tubular dysfunction and low plasma vitamin C concentration. METHODS: This was a non-randomized cross-sectional cohort study of males with Fabry disease (n = 34) and healthy male controls (n = 33). To determine primary outcome of vitamin C renal leak, matched urine and fasting plasma vitamin C measurements were obtained following an overnight fast. Based on data from healthy men, vitamin C renal leak was defined as presence of urinary vitamin C at plasma concentrations below 38 µM. Exploratory outcomes assessed the association between renal leak and clinical parameters; and genomic associations with renal leak using single nucleotide polymorphisms (SNPs) in the vitamin C transporter SLC23A1. Proof-of-concept studies were conducted using two mouse models. RESULTS: Compared with healthy men, Fabry cohort had 16-fold higher odds of renal leak (6% vs 52%: OR16, P < 0.001). Renal leak was associated with higher protein creatinine ratio (p = 0.01), lower hemoglobin (p = 0.002) and hematocrit (p = 0.008). Renal leak, but not plasma vitamin C, was associated with a non-synonymous single nucleotide polymorphism in vitamin C transporter SLC23A1 (p = 0.01 and p = 0.47 respectively). Using two mouse models, we recapitulated the relationships between renal leak, dysregulated vitamin C renal reabsorption and low plasma vitamin C concentrations. CONCLUSIONS: Increased prevalence of vitamin C renal leak in Fabry disease may result from dysregulated vitamin C renal physiology, with significant clinical and genomic associations. Renal leak may be more sensitive than plasma vitamin C in evaluating genomic associations in small cohorts. FUNDING SOURCES: Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda MD 20,892–1372.